Innovative Health Sciences, LLC – Trademark Portfolio
Entity Type: 16
Innovative Health Sciences, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include IHS, ONESETT, INSIGNIS, INNOVATIVE HEALTH SCIENCES, and IHS INNOVATIVE HEALTH SCIENCES. The owner is based in Chester, NY.
1108 Kings Highway, Suite #4
Chester, NY 10918
Showing of trademarks Trademarks
Trademark Classifications
Innovative Health Sciences, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Innovative Health Sciences, LLC have?
Innovative Health Sciences, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned.
What trademark classes does Innovative Health Sciences, LLC file in?
Innovative Health Sciences, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Innovative Health Sciences, LLC's most well-known trademarks?
Innovative Health Sciences, LLC's registered trademark portfolio includes well-known marks such as IHS, ONESETT, INSIGNIS, INNOVATIVE HEALTH SCIENCES, and IHS INNOVATIVE HEALTH SCIENCES. These are among 5 currently registered trademarks in the portfolio.
What is Innovative Health Sciences, LLC's trademark registration success rate?
Innovative Health Sciences, LLC has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.